InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Zalevsky
30 Jun 2026
Chief R&D Officer
Sold on a plan
5,681
$70.00
$397.67K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
4,500
$61.65
$277.43K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
5,500
$60.81
$334.46K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
4,697
$60.71
$285.15K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
5,303
$59.97
$318.02K
Jonathan Zalevsky
15 Jun 2026
Chief R&D Officer
Sold on a plan
5,538
$60.71
$336.21K
Jonathan Zalevsky
20 Jan 2026
Chief R&D Officer
Sold on a plan
3,867
$35.67
$137.94K
Show all 16 transactions →

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 49,596
History held since 7 Nov 2006